Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy

Kidney International

Volumn 49, Issue 2, 1996, Pages 571-577

  Hunley, Tracy E ^b   Julian, Bruce A ^b   Phillips III, John A ^b   Summar, Marshal L ^b   Yoshida, Hiroaki ^b   Horn, Robert G ^b   Brown, Nancy J ^b   Fogo, Agnes ^b   Ichikawa, Iekuni ^b   Kon, Valentina ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SILENCER GENE;

EID: 9044227268     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.81     Document Type: Article

References (38)

1. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G, BARD J-M, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
2. SCHUNKERT H, HENSE H-W, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
3. BONNARDEAUX A, DAVIES E, JEUNEMAITRE X, FERY I, CHARRU A, CLAUSER E, TIRET L, CAMBIEN F, CORVOL P, SOUBRIER F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69, 1994
4. TIRET L, BONNARDEAUX A, POIRIER O, RICARD S, MARQUES-VIDAL P, EVANS A, ARVEILER D, LUC G, KEE F, DUCIMETIÈRE P, SOUBRIER F, CAMBIEN F: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet 334:910-913, 1994
5. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL J-M, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
6. CAULFIELD M, LAVENDER P, FARRALL M, MUNROE P, LAWSON M, TURNER P, CLARK AJL: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-33, 1994
7. BERGER J, HINGLAIS N: Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 74:694-695, 1968
8. JULIAN B, WALDO F, RIFAI A, MESTECKY J: IgA nephropathy, the most common glomerulonephritis worldwide. Am J Med 84:129-132, 1988
9. JULIAN BA, VAN DEN WALL BAKE AWL: IgA Nephropathy, in Textbook of Nephrology 3rd ed), edited by MASSRY SG, GLASSOCK RJ, Baltimore, Williams and Wilkins, 1995, pp 752-760
10. GALLA JH: IgA nephropathy. (Editorial Review) Kidney Int 47:377-387, 1995
11. 1 receptor C variant in hypertensive African Americans. (abstract) Circulation (in press)
12. RUTLEDGE DR, BROWE CS, ROSS EA: Frequencies of the angiotensinogen gene and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Biochem Molec Biol Int 34: 1271-1275, 1994
13. World Health Organization Classification of IgA Nephropathy, in Renal Disease, Classification and Atlas of Glomerular Diseases 2nd ed), edited by CHURG J, BERNSTEIN J, GLASSOCK RJ, New York, Igaku-Shoin, 1995
14. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 153:154-183, 1993
15. VNENCAK-JONES CL, PHILLIPS JA III, DE-FEN W: Use of polymerase chain reaction in detection of growth hormone gene deletions. J Clin Endo Metab 70:1550-1553, 1990
16. HUBERT C, HOUOT AM, CORVOL P, SOUBRIER F: Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 266:15377-15383, 1991
17. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
18. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, KANAI T, MIYAZAKI Y, KAWAGUCHI Y, KUBO H, NAGASAWA R, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest (in press)
19. SHANMUGAM V, SELL KW, SAHA BK: Mistyping ACE heterozygotes. PCR Meth Appl 3:120-121, 1993
20. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, BURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
21. KARLSEN F, KALANTARI M, CHITEMERERE M, JOHANSSON B, HAGMAR B: Modification of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 71:604-611, 1994
22. ROTIMI C, MORRISON L, COOPER R, OYEJIDE C, EFFIONG E, LADIPO M, OSOTEMIHEN B, WARD R: Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans. Hypertension 24:591-594, 1994
23. KUPARI M, PEROLA M, KOSKINEN P, VIROLAINEN J, KARHUNEN PJ: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 267:H1107-H1111, 1994
24. MANSFIELD JC, HOLDEN H, TAKLOW JK, DI GIOVINE FS, MCDOWELL TL, WILSON AG, HOLDSWORTH CD, DUFF GW: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterol 106:637-642, 1994
25. BLAKEMORE AIF, TARLOW JK, CORK MJ, GORDON C, EMERY P, DUFF GW: Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37:1380-1385, 1994
26. TARLOW JK, CLAY FE, CORK MJ, BLAKEMORE AIF, MCDONAGH AJG, MESSENGER AG, DUFF GW: Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103:387-390, 1994
27. HARDEN PN, GEDDES C, ROWE PA, MCILROY JH, BOULTON-JONES M, STUART R, RODGER C, JUNOR BJR, BRIGGS JD, CONNELL JMC, JARDINE AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542, 1995
28. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
29. YAMADA T, HORIUCHI M, MORISHITA R, ZHANG L, PRATT RE, DZAU VJ: In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest 96:1230-1237, 1995
30. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25: 1266-1269, 1995
31. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, FOR THE COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
32. KASISKE BL, KALIL RSN, MA JZ, LIAO M, KEANE WF: Effects of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Int Med 118:129-138, 1993
33. FERIOZZI S, PIERUCCI A, ROSCIA E, CINOTTI GA, PECCI G: Angiotensin converting enzyme inhibition delays the progression of chronic renal failure in hypertensive patients with immunoglobulin A nephropathy. J Hypertens 7(Suppl):S63-S64, 1989
34. CATTRAN DC, GREENWOOD C, RITCHIE S: Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kid Dis 23:247-254, 1994
35. DAHLOF B, PENNERT K, HANSSON L: Regression of left ventricular hypertrophy - A meta-analysis. Clin Exp Hypertens A14:173-180, 1992
36. LIEBERMANN J, SASTRE A: Serum angiotensin-converting enzyme: Elevations in diabetes mellitus. Ann Int Med 93:825-826, 1980
37. HALLAB M, BLED F, EBRAN JM, SURANITI S, GIRAULT A, FRESSINAUD P, MARRE M: Elevated serum angiotensin converting enzyme activity in type I, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29:82-85, 1992
38. ALLAN DR, MCKNIGHT JA, KIFOR I, COLETTI CM, HOLLENBERG NK: Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-522, 1994